HB 712 Summary

• Prohibits drug manufacturers from denying, restricting, or prohibiting the acquisition, shipping, or delivery of 340B drugs to pharmacies contracted with 340B covered entities participating in the federal 340B Drug Pricing Program.

• Authorizes 340B covered entities and the Attorney General to bring civil actions for enforcement within four years of a violation, with covered entities entitled to injunctive relief and attorney's fees if successful.

• Establishes fines of $500 to $2,500 per violation for manufacturers that breach the prohibition, with each day of violation constituting a separate violation.

• Requires each 340B covered entity to report annually to Hawaii's hospital trade association (beginning July 1, 2026) regarding contract pharmacy usage, including acquisition costs, payor reimbursements, prescriptions filled, and number of contract pharmacies.

• Requires the hospital trade association to compile and publicly post aggregate annual reports of all 340B covered entities' information (beginning October 1, 2027).